Remus Pharmaceuticals
₹7,289.6
-166.55 (-2.23%)
13 May, 2024 18:06 BSE:
NSE: REMUSISIN: INE0O5T01011
Start SIP in Remus Pharmaceuticals
Start SIPRemus Pharmaceuticals Performance
Day Range
- Low 7,261
- High 7,550
52 Week Range
- Low 1,711
- High 8,747
- Open Price7,450
- Previous Close7,456
- Volume875
Remus Pharmaceuticals Financials
Indicator | Mar 2023 |
---|---|
Total Revenue Annual Cr | 47 |
Operating Expenses Annual Cr | 34 |
Operating Profit Annual in Cr | 11 |
Depreciation Cr | 0 |
Interest Annual Cr | 0 |
Tax Annual Cr | 3 |
Net Profit Annual Cr | 9 |
Remus Pharmaceuticals Technicals
EMA & SMA
Current Price
₹7,289.6
-166.55 (-2.23%)
- Bullish Moving Average
- ___
- 11
- Bearish Moving Average
- ___
- 5
- 20 Day
- ₹7,157.38
- 50 Day
- ₹6,733.00
- 100 Day
- ₹6,372.92
- 200 Day
- ₹5,565.04
- 20 Day
- ₹7,088.07
- 50 Day
- ₹6,394.65
- 100 Day
- ₹6,586.62
- 200 Day
- ₹5,729.48
Remus Pharmaceuticals Resistance and Support
PIVOT
₹7,366.87
Resistance | |
---|---|
First Resistance | 7,472.73 |
Second Resistance | 7,655.87 |
Third Resistance | 7,761.73 |
RSI | 53.83 |
MFI | 72.23 |
MACD Single Line | 350.22 |
MACD | 310.85 |
Support | |
---|---|
First Resistance | 7,183.73 |
Second Resistance | 7,077.87 |
Third Resistance | 6,894.73 |
Remus Pharmaceuticals Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 775 | 62,504 | 80.65 |
Week | 2,460 | 178,498 | 72.56 |
1 Month | 5,126 | 304,349 | 59.37 |
6 Month | 2,577 | 172,946 | 67.12 |
Remus Pharmaceuticals Result Highlights
Remus Pharmaceuticals Synopsis
NSE-Medical-Whlsle Drg/Suppl
Remus Pharmaceutic belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 45.03 Cr. and Equity Capital is Rs. 1.09 Cr. for the Year ended 31/03/2023. Remus Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 21/09/2015 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is U24232GJ2015PLC084536 and registration number is 084536.Market Cap | 1,070 |
Sales | 45 |
Shares in Float | 0.04 |
No of funds | 3 |
Yield | 0.03 |
Book Value | 42.28 |
U/D Vol ratio | 1.1 |
LTDebt / Equity | 37 |
Alpha | 0.55 |
Beta | 1.5 |
Remus Pharmaceuticals
Owner Name | Mar-24 | Sep-23 |
---|---|---|
Promoters | 70.6% | 69.61% |
Foreign Portfolio Investors | 3.25% | 2.38% |
Financial Institutions/ Banks | ||
Individual Investors | 20.54% | 21.15% |
Others | 5.61% | 6.86% |
Remus Pharmaceuticals Management
Name | Designation |
---|---|
Mr. Swapnil Jatinbhai Shah | Chairman & Wholetime Director |
Mr. Arpit Deepakkumar Shah | Managing Director |
Mrs. Anar Swapnil Shah | Whole Time Director |
Ms. Roma Vinodbhai Shah | Whole Time Director |
Mr. Balwant Purohit | Independent Director |
Mrs. Sanjana Sanjeev Shah | Independent Director |
Mr. Vishrut Chandramauli Pathak | Independent Director |
Remus Pharmaceuticals Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Remus Pharmaceuticals Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-04-23 | Bonus issue & Interim Dividend | |
2024-04-22 | Interim Dividend |
Date | Purpose | Remarks |
---|---|---|
2024-05-02 | INTERIM | Rs.0.00 2nd interim dividend of Rs. 4.00/- (Rupees Four only) per equity share having face value of Rs. 10/- each for the financial year 2023-24. |
2023-10-28 | INTERIM | Rs.0.00 Interim Dividend of Rs. 2 per equity share. |
Remus Pharmaceuticals FAQs
What is Share Price of Remus Pharmaceuticals ?
Remus Pharmaceuticals share price is ₹7,289 As on 13 May, 2024 | 17:52
What is the Market Cap of Remus Pharmaceuticals ?
The Market Cap of Remus Pharmaceuticals is ₹1073.8 Cr As on 13 May, 2024 | 17:52
What is the P/E ratio of Remus Pharmaceuticals ?
The P/E ratio of Remus Pharmaceuticals is As on 13 May, 2024 | 17:52
What is the PB ratio of Remus Pharmaceuticals ?
The PB ratio of Remus Pharmaceuticals is 56.1 As on 13 May, 2024 | 17:52